NDC product
Tension Headache Relief
NDC 84324-002 · NUVICARE LLC
Key facts
| Product NDC | 84324-002 |
|---|---|
| Proprietary name | Tension Headache Relief |
| Nonproprietary name | ACETAMINOPHEN, CAFFEINE |
| Substances | ACETAMINOPHEN, CAFFEINE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | NUVICARE LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M013 |
| Pharmacologic classes | Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS] |
| Marketing start | Jul 30, 2024 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: